IRIS
BELLAN, CRISTIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.668
EU - Europa 10.086
AS - Asia 5.402
SA - Sud America 808
AF - Africa 304
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 7
Totale 28.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.489
GB - Regno Unito 2.522
RU - Federazione Russa 2.004
CN - Cina 1.914
SG - Singapore 1.617
IE - Irlanda 1.230
IT - Italia 1.103
DE - Germania 733
BR - Brasile 692
SE - Svezia 657
UA - Ucraina 633
FR - Francia 548
VN - Vietnam 515
HK - Hong Kong 473
FI - Finlandia 282
KR - Corea 262
IN - India 160
ZA - Sudafrica 157
TR - Turchia 104
CA - Canada 102
BD - Bangladesh 86
PL - Polonia 63
ES - Italia 61
NL - Olanda 57
BE - Belgio 50
IQ - Iraq 50
AR - Argentina 47
MX - Messico 43
AT - Austria 39
JP - Giappone 32
PK - Pakistan 30
CI - Costa d'Avorio 29
KE - Kenya 29
NG - Nigeria 29
ID - Indonesia 26
SA - Arabia Saudita 20
EC - Ecuador 19
MA - Marocco 18
VE - Venezuela 17
CZ - Repubblica Ceca 15
AU - Australia 14
UZ - Uzbekistan 14
CL - Cile 11
AZ - Azerbaigian 10
CH - Svizzera 10
IL - Israele 10
LT - Lituania 10
NP - Nepal 10
CO - Colombia 9
RO - Romania 9
TN - Tunisia 9
DO - Repubblica Dominicana 8
GR - Grecia 8
IR - Iran 8
AL - Albania 7
EU - Europa 7
JO - Giordania 7
PA - Panama 7
PT - Portogallo 7
UG - Uganda 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
JM - Giamaica 6
MY - Malesia 6
KG - Kirghizistan 5
LV - Lettonia 5
PE - Perù 5
PH - Filippine 5
TT - Trinidad e Tobago 5
AO - Angola 4
BG - Bulgaria 4
CR - Costa Rica 4
KZ - Kazakistan 4
MT - Malta 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
UY - Uruguay 4
AM - Armenia 3
EE - Estonia 3
NO - Norvegia 3
OM - Oman 3
PS - Palestinian Territory 3
PY - Paraguay 3
RS - Serbia 3
SI - Slovenia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
MM - Myanmar 2
PW - Palau 2
SY - Repubblica araba siriana 2
Totale 28.276
Salva come PNG Salva come JPEG
Città #
Southend 2.290
Dallas 1.235
Dublin 1.192
Fairfield 1.037
Singapore 946
Ashburn 862
Houston 710
Chandler 641
Moscow 582
Santa Clara 565
Jacksonville 536
Beijing 519
Woodbridge 497
Hong Kong 453
San Jose 417
Siena 396
Wilmington 392
Seattle 356
Ann Arbor 346
Hefei 316
Cambridge 312
Seoul 259
Princeton 241
New York 217
Menlo Park 216
Los Angeles 202
Nanjing 185
The Dalles 177
Ho Chi Minh City 153
Johannesburg 143
Munich 140
Lauterbourg 130
Council Bluffs 110
Helsinki 101
Hanoi 95
Milan 91
Boardman 86
Florence 78
Dong Ket 77
Buffalo 76
Dearborn 76
Nanchang 74
São Paulo 74
San Mateo 72
Shanghai 72
Izmir 67
San Diego 61
Turku 55
Warsaw 51
Brussels 49
Chicago 46
Orem 46
Málaga 44
London 41
Rome 41
Columbus 39
Montreal 39
Düsseldorf 37
Bengaluru 36
Shenyang 36
Tianjin 34
Frankfurt am Main 33
Fremont 32
Denver 31
Lappeenranta 31
Redondo Beach 30
Abidjan 29
Toronto 29
Abuja 28
Hebei 28
San Francisco 28
Atlanta 27
Jiaxing 27
Brooklyn 26
Changsha 26
Phoenix 26
Chennai 25
Kunming 24
Tokyo 24
Guangzhou 23
Sezze 23
Belo Horizonte 21
Manchester 21
Vienna 21
Amsterdam 20
Stockholm 19
Da Nang 18
Falls Church 18
Haiphong 18
Jinan 18
Nuremberg 18
Baghdad 17
Mexico City 17
Norwalk 17
Poplar 17
Rio de Janeiro 17
Bologna 16
Scarperia 16
Washington 16
Zhengzhou 16
Totale 19.358
Salva come PNG Salva come JPEG
Nome #
Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach 567
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 393
Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment 354
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 347
Omic Approach in Non-Smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine 344
B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression 342
Analisi del riarrangiamento e delle mutazioni del gene VH delle immunoglobuline nelle cellule B monocitoidi M-IRTA-1 positive. 331
Frequent Traces of EBV Infection in Hodgkin and non-Hodgkin Lymphomas Classified as EBV-negative by Routine Methods: Expanding the Landscape of EBV-related Lymphomas 330
Unveiling another missing piece in EBV-driven lymphomagenesis: EBV-encoded microRNAs expression in EBER-negative Burkitt lymphoma cases 326
Analysis of the IgVH genes in T cell-mediated and antibody-mediated rejection of the kidney graft. 323
Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic burkitt lymphoma suggests antigen drive activation of bcr as opposed to sporadic burkitt lymphoma 317
Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature 317
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma 313
Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity 304
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. 300
VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues. 296
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 296
Preferential usage of specific immunoglobulin heavy chain variable region genes with unmutated profile and advanced stage at presentation are common features in patients with chronic lymphocytic leukemia from Senegal 293
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 290
Alteration of microRNAs regulated by c_Myc in Burkitt lymphoma 281
Identification of single-nucleotide variants by high-throughput RNA sequencing in endemic Burkitt Lymphoma 275
Burkitt lymphoma versus diffuse large B-cell lymphoma: A practical approach 271
EBV reactivation influences clonal evolution in HHV8 related lymphoprolipherative disorders? 270
CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation 261
Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1 258
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas 257
Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors 255
Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells 253
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 253
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes 252
HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas 249
Anaplastic large cell lymphomas and Hodgkin's disease: distinctive growth features and expression of p34cdc2 /cyclin B-1 242
Burkitt’s lymphoma: new insights into molecular pathogenesis 239
A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis 238
Analysis of rearrangement and Vh gene mutations and correlation with the expression of M-IRTA 1 in monocytoid B cells of toxoplasmic lymphadenitis. 237
Gene expression analysis uncovers similarty and differences among Burkitt lymphoma subtypes 235
Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas? 234
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach 234
Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia 229
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in anti-apoptotic and chromatin-remodeling genes. 227
Activation of MyoD-dependent transcription by cdk9/cyclin T2 226
Anaplastic large cell lymphomas and Hodkin’s disease: distinctive growth features and expression of p34cdc2/cyclin B-1 222
The role of the Cdk9/Cyclin T1 complex in T cell differentiation 220
Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines 219
CDK9/Cyclin T expression in reactive lymph nodes and malignant lymphomas. 214
Oct-4 is highly expressed in stem/ progenitor cells and in primordial follicles of the fetal human ovary 213
FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. 209
Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin 209
Altered expression of miRNAs in c-Myc negative Burkitt lymphoma cases 209
Immunoglobulin gene rearrangement analysis in composite Hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells? 208
Analysis of primary cilium expression and hedgehog pathway activation in mesothelioma throws back its complex biology 206
Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis 203
DNMT over-expression based on microRNA modulation in HIV-related aggressive B-cell lymphomas 199
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 198
Lymphoepithelial-like carcinoma of the parotid gland: a case report and a brief review of the western literature 196
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation 196
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 196
CDK9/Cyclin T expression in reactive lymph nodes and malignant lymphomas. 195
Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo 194
Are periodontitis and psoriasis associated? A pre-clinical murine model 192
Cell growth and death in malignant lymphomas. A quantitative analysis. 191
The Personalized Inherited Signature Predisposing to Non-Small-Cell Lung Cancer in Non-Smokers 188
CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection 186
Retinoblastoma gene family expression in lymphoid tissues 186
Pseudolymphoma of the kidney associated with high-grade bladder urothelial carcinoma 186
Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysis 185
Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms 183
Role of EBV in microRNA dysregulation in Burkitt lymphoma 183
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation 182
IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. 182
Tumor-Suppressor Genes as Diagnostic Tools 181
MicroRNA expression profile identifies a distinct molecular signature between MYC translocation-positive and negative Burkitt lymphoma cases 180
Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation 180
Cell kinetics and cell cycle regulation in lymphomas. 179
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations 178
The XLMR gene ACSL4 plays a role in dendritic spine architecture 178
P53 mutation in breast cancer, correlation with cell kinetics and cell of origin 177
Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes 177
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis 176
Physical interaction between pRb and cdk9/cyclin T2 complex 175
Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications. 174
Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma (Cell Death & Disease, (2020), 11, 9, (748), 10.1038/s41419-020-02940-w) 171
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 170
P53 mutation in breast cancer correlation with cell kinetics and cell of origin 168
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) 168
TAVR and Dialysis Are a Challenging Combination. A Case Report and Systematic Review of Literature 167
Pathologic aspects of AIDS malignancies 166
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 165
Renal sinus pseudolymphoma in a patient with multiple carcinomas: a case report and a brief review of the literature. 164
null 164
Predictive prognostic factors of surgically treated intra-pulmonary mettstases from colorectal carcinomas: a 30 years retrospective analysis 163
Sarcoid Nodule or Lung Cancer? A High-Resolution Computed Tomography-Based Retrospective Study of Pulmonary Nodules in Patients with Sarcoidosis 162
Expression of p34(cdc2) and cyclin B-1 in Hodgkin's disease and anaplastic large cell lymphomas 162
null 161
The interaction between HIV-1 Tat and pRb2/p130: a possibile mechanisms in the pathogenesis of AIDS-related neoplasms. 160
null 160
Mesothelioma malignancy and the microenvironment: Molecular mechanisms 157
Linking regional administrative data with an hospital pathology registry in Italy to describe first-line pharmacotherapy of non-resectable non-small cell lung cancer in 2009-2017 156
Washout-Computed Tomography Discriminates Pulmonary "Fat-poor" Hamartomas From Neuroendocrine Neoplasms A Simple Method in the Radiomics Era 152
Geographic variation and environmental conditions as cofactors in Chlamydia psittaci association with ocular adnexal lymphomas: a comparison between Italian and African samples 152
Totale 22.652
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.882
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021392 0 0 0 0 0 0 0 0 0 0 193 199
2021/20221.819 118 210 112 204 103 65 86 127 74 193 140 387
2022/20232.448 145 211 338 336 243 477 50 214 236 66 80 52
2023/20241.910 77 48 194 69 58 576 627 27 30 55 23 126
2024/20254.006 98 217 383 206 559 213 86 222 336 161 437 1.088
2025/20268.994 739 1.297 1.034 1.190 1.880 359 1.099 316 334 525 221 0
Totale 28.581